A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma
Clinical trial NCT07105592 · RECRUITING
Trial details
- NCT number
- NCT07105592
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-13
- Primary completion
- 2027-05-31
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.